Scholars Central

Conference abstractPublished 13 Aug 2012

A novel concept and a cost-effective method to counteract side-effects of non-steroidal anti-inflammatory drugs (NSAIDs): Modulation of biosynthesis of prostaglandin E2

Authors: Liubov Gargaun

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

N SAIDs are well-tolerated, however, considering their widespread use, clinicians continue to face the significant challenge of their serious side-effects associated with reduced prostaglandin E2 (PGE2). PGE2 plays physiological roles in gastrointestinal, renal and other systems and reducing levels of PGE2 in NSAID treatment may cause gastroduodenal ulcers, hypertension, and other side-effects. Unreduced PGE2 levels during NSAID treatment could prevent or mitigate these serious side-effects. Pyridine derivatives (PDs) have been found to modulate biosynthesis of PGE2. Some of them, mostly non- expensive drugs, such as nicotine, nicotinic acid, nicotinyl alcohol, pyridinol carbamate, pyridoxine hydrochloride, niceritrol and pyridostigmine bromide increase levels of endogenous PGE2. Based on Student�s t-test statistical analysis, as performed by us, of data extracted from unrelated peer-reviewed publications of studies involving NSAIDs, PGE2 and PDs completed in vitro and on healthy volunteers (Takahashi, H., 2007; Takahashi, H., 2006; Nozaki, S., 1987; Sahin, I., 1984; Eklund, B., 1979), we found and demonstrated that increased levels of PGE2 by the abovementioned PDs were not reduced by NSAIDs (COX1- and COX2- inhibitors) below physiological levels. This effect was missed by publications� authors. Modulation of biosynthesis of PGE2 in NSAIDs treatment is a novel concept that we are proposing and use of PDs can serve as proof of the mechanism and may offer a new promising cost-effective method to accomplish the high unmet medical need in prevention or mitigation of suppressing side-effect of NSAIDs (COX1- and COX2-inhibitors) on PGE2. Although the use of NSAIDs and PDs may have been described, it has not been observed before that modulation of biosynthesis of PGE2 by PDs does not allow NSAIDs to reduce PGE2 levels below physiological levels

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

More from this journal

The newest in Rheumatology: Current Research.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalRheumatology: Current Research
  • SubjectRheumatology
  • SubjectOrthopaedics
  • BylineArticles whose byline prints “Liubov Gargaun”